生物外科市场规模、份额和成长分析（按产品、应用、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，生物外科市场规模将达到 166.3 亿美元，到 2025 年将达到 177.8 亿美元，到 2033 年将达到 303.2 亿美元，在预测期（2026-2033 年）内，复合年增长率为 6.9%。

由于政府和私营部门投资增加，以及医疗设备领域研发投入不断成长，全球生物外科市场预计将显着成长。关键成长要素包括慢性病激增、择期手术需求上升以及医疗基础设施的大量投资。人口老化和严重创伤发生率上升也显着推动了市场扩张。越来越多的医疗保健公司生产创新生物外科产品，进一步巩固了这一成长势头。手术量的增加和运动相关伤害的增加进一步推动了对生物外科解决方案的需求，而医疗设备和製药业持续的研发投入则为市场发展创造了充满希望的机会。总而言之，这些因素共同作用，增强了生物外科市场的发展前景。

生物外科市场驱动因素

全球生物外科市场正经历显着成长，其主要驱动力是糖尿病、肥胖和心臟病等慢性疾病的日益增加。这些健康问题通常需要手术干预，因此对能够促进癒合、提高手术成功率的创新生物外科解决方案的需求不断增长。随着医疗机构寻求能够帮助患者康復并优化手术技术的先进产品，生物外科产品市场持续扩张。科技的不断进步以及对透过有效手术介入改善患者照护的日益重视，进一步推动了这项需求。

生物外科市场限制因素

生物外科市场面临的主要挑战之一是缺乏对最新技术和产品的认知和培训。许多医疗专业人员并不完全了解先进生物外科技术的益处和应用，这可能导致这些技术未能充分利用。这种教育差距有可能阻碍创新方法的采用，并最终抑制外科手术实践的改进。如果缺乏足够的知识和培训，这些先进生物外科技术的潜力可能无法充分发挥，从而阻碍市场成长和外科技术的整体发展，最终影响患者的福祉。

生物外科市场趋势

全球生物外科市场的一大趋势是微创手术技术的日益普及。这项转变得益于外科技术和设备的进步，这些进步能够改善患者的治疗效果并缩短復原时间。随着医疗机构将患者安全和舒适度置于首位，生物聚合物、止血剂和密封剂等生物外科产品因其在创伤治疗和组织修復方面的有效性而备受关注。此外，慢性疾病的增加以及对先进外科手术介入的需求，也推动了生物外科领域的研究和创新，重点在于整合生物材料以提高手术疗效。

目录

介绍

• 调查目标
• 定义
• 市场覆盖范围

调查方法

• 资讯收集
• 二手和一手资料资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

前景
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场动态
  • 司机
  • 机会
  • 抑制因素
  • 任务
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 监管分析
• 供应链分析

生物外科市场产品分类

• 骨移植替代物
  • 去矿骨基质
  • 合成骨移植材料
  • 骨形成蛋白
  • 其他骨移植替代物
• 软组织固定装置
  • 合成网
  • 生物网膜
  • 同种异体移植
  • 异质骨移植
• 止血剂
  • 基于凝血酶的止血剂
  • 氧化再生纤维素止血剂
  • 复方止血剂
• 外科密封剂和黏合剂
  • 天然/生物来源密封剂和黏合剂
  • 按类型
  • 纤维蛋白基密封剂和黏合剂
  • 胶原蛋白基密封剂和黏合剂
  • 明胶基密封剂和黏合剂
  • 蛋白基密封剂
  • 其他天然/生物来源密封剂和黏合剂
  • 按原料
  • 动物源性密封剂和黏合剂
  • 人血衍生密封剂和黏合剂
  • 合成和半合成密封剂和黏合剂
  • 基于聚乙二醇水凝胶的密封剂和黏合剂
  • 氰基丙烯酸酯密封剂和黏合剂
  • 胺甲酸乙酯密封剂和黏合剂
  • 其他合成和半合成密封剂和黏合剂
• 防沾黏剂
  • 合成抗黏附剂
  • 玻尿酸抗沾黏剂
  • 再生纤维素基防黏剂
  • 聚乙二醇（PEG）防沾剂
  • 其他合成抗黏附剂
  • 天然防沾剂
  • 胶原蛋白和蛋白质黏附抑制剂
  • 纤维蛋白基抗黏连剂
• 钉线加固

生物外科市场按应用领域划分

• 整形外科手术
• 一般外科
• 神经外科
• 心血管外科
• 重组手术
• 妇科手术
• 泌尿系统
• 胸腔外科
• 其他用途

生物外科市场（按最终用户划分）

• 医院
• 诊所
• 其他最终用户

按地区分類的生物外科市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲（MEA）
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争格局

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市占率（2025 年）

主要企业简介

• Baxter International Inc.（US）
• B. Braun Melsungen AG（Germany）
• Becton, Dickinson & Company（US）
• Johnson & Johnson（US）
• Medtronic Plc（Ireland）
• Integra Lifesciences Holdings Corporation（US）
• Commonwealth Serum Laboratories Limited（Australia）
• Hemostasis LLC（US）
• Pfizer Inc.（US）
• Stryker Corporation（US）
• Zimmer Biomet（US）
• Kuros Biosciences AG（Switzerland）
• Orthofix Medical Inc.（US）
• Smith & Nephew Plc（UK）
• Tissue Regenix Group Plc（UK）
• Betatech Medical（Turkey）
• Meril Life Sciences Pvt. Ltd.（India）
• Samyang Holdings Corporation（South Korea）
• Aroa Biosurgery Ltd.（New Zealand）
• Meyer-Haake Gmbh（Germany）
• Biom Up（France）
• Biocer Entwicklungs-Gmbh（Germany）
• Hannox International Corp.（Taiwan）

Biosurgery Market size was valued at USD 16.63 Billion in 2024 and is poised to grow from USD 17.78 Billion in 2025 to USD 30.32 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global biosurgery market is poised for substantial growth due to increased investments from governmental and private sectors in the medical device arena, coupled with rising R&D expenditures. Key drivers include the surging prevalence of chronic diseases, heightened demand for elective surgeries, and substantial funding for healthcare infrastructure. The aging population and the rising incidence of severe traumatic injuries also contribute significantly to market expansion. The growing number of medical firms manufacturing innovative biosurgery products further supports this growth trajectory. Increased surgical procedures and sports-related injuries are further propelling the demand for biosurgery solutions, while ongoing R&D efforts within the medical device and pharmaceutical industries create promising opportunities for market evolution. Overall, these factors collectively enhance the biosurgery landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biosurgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biosurgery Market Segments Analysis

Global Biosurgery Market is segmented by Product, Application, End User, end user and region. Based on Product, the market is segmented into Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants & Adhesives, Adhesion Barriers, Staple-Line and Reinforcement Agents. Based on Application, the market is segmented into Orthopedic Surgery, General Surgery,Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Urological Surgery, Thoracic Surgery, and Other Applications. Based on End User, the market is segmented into Hospitals, Clinics, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Biosurgery Market

The global biosurgery market is experiencing significant growth driven by the rising prevalence of chronic diseases such as diabetes, obesity, and heart conditions. These health issues frequently necessitate surgical interventions, leading to an increased demand for innovative biosurgical solutions that promote healing and enhance the likelihood of successful surgical outcomes. As healthcare providers seek advanced products that can support patient recovery and optimize surgical techniques, the market for biosurgery items continues to expand. This demand is fueled by ongoing advancements in technology and an emphasis on improving patient care through effective surgical interventions.

Restraints in the Biosurgery Market

One of the significant challenges facing the biosurgery market is the limited awareness and training surrounding the latest techniques and products. Many healthcare professionals may not fully recognize the benefits and applications of advanced biosurgical methods, resulting in their underutilization. This educational gap can impede the adoption of innovative approaches, ultimately stalling progress in the enhancement of surgical practices. Without sufficient knowledge and training, the potential of these advanced biosurgical options may remain unexploited, thereby curtailing market growth and the overall evolution of surgical techniques that could benefit patients.

Market Trends of the Biosurgery Market

A significant market trend in the global biosurgery market is the increasing adoption of minimally invasive surgical procedures. This shift is driven by advancements in surgical techniques and technologies, which enhance patient outcomes and reduce recovery times. As healthcare providers prioritize patient safety and comfort, biosurgery products-such as biopolymers, hemostatic agents, and sealants-are gaining traction for their efficacy in wound healing and tissue repair. Additionally, the growing prevalence of chronic diseases and the need for advanced surgical interventions are propelling research and innovation in biosurgery, with a focus on integrating biological materials to improve surgical efficacy.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Analysis
• Supply Chain Analysis

Biosurgery Market by Product

• Market Overview
• Bone-Graft Substitutes
  • Demineralized Bone Matrix
  • Synthetic Bone Grafts
  • Bone Morphogenetic Proteins
  • Other Bone-Graft Substitutes
• Soft-Tissue Attachments
  • Synthetic Meshes
  • Biological Meshes
  • Allografts
  • Xenografts
• Hemostatic Agents
  • Thrombin-Based Hemostatic Agents
  • Oxidized Regenerated Cellulose-Based Hemostatic Agents
  • Combination Hemostatic Agents
• Surgical Sealants & Adhesives
  • Natural/Biological Sealants & Adhesives
  • By Type
  • Fibrin-Based Sealants & Adhesives
  • Collagen-Based Sealants & Adhesives
  • Gelatin-Based Sealants & Adhesives
  • Albumin-Based Sealants
  • Other Natural/Biological Sealants & Adhesives
  • By Origin
  • Animal-Based Sealants & Adhesives
  • Human Blood-Based Sealants & Adhesives
  • Synthetic And Semi-Synthetic Sealants & Adhesives
  • PEG Hydrogel-Based Sealants & Adhesives
  • Cyanoacrylate-Based Sealants & Adhesives
  • Urethane-Based Sealants & Adhesives
  • Other Synthetic and Semi-Synthetic Sealants & Adhesives
• Adhesion Barriers
  • Synthetic Adhesion Barriers
  • Hyaluronic Acid-Based Adhesion Barriers
  • Regenerated Cellulose-Based Adhesion Barriers
  • PEG-Based Adhesion Barriers
  • Other Synthetic Adhesion Barriers
  • Natural Adhesion Barriers
  • Collagen And Protein Adhesion Barriers
  • Fibrin-Based Adhesion Barriers
• Staple-Line Reinforcement Agents

Biosurgery Market by Application

• Market Overview
• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Reconstructive Surgery
• Gynecological Surgery
• Urological Surgery
• Thoracic Surgery
• Other Applications

Biosurgery Market by End User

• Market Overview
• Hospitals
• Clinics
• Other End Users

Biosurgery Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• Baxter International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson & Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra Lifesciences Holdings Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Commonwealth Serum Laboratories Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemostasis LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tissue Regenix Group Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Betatech Medical (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samyang Holdings Corporation (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aroa Biosurgery Ltd. (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meyer-Haake Gmbh (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biom Up (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocer Entwicklungs-Gmbh (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hannox International Corp. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments